Back
Ocular Therapeutix Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
63
OCUL
Ocular Therapeutix
Last Price:
9.56
Seasonality Move:
41.77%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MOREOcular Therapeutix Price Quote
$9.56
+0.12 (+1.27%)
(Updated: December 11, 2024 at 5:55 PM ET)
Ocular Therapeutix Key Stats
Buy
63
Ocular Therapeutix (OCUL)
is a Buy
Day range:
$9.23 - $9.51
52-week range:
$3.25 - $11.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.32
P/B ratio:
4.22%
Volume:
606.8K
Avg. volume:
941.6K
1-year change:
160.77%
Market cap:
$1.5B
Revenue:
$58.4M
EPS:
$-1.32
How Much Does Ocular Therapeutix Make?
-
How Much Are Ocular Therapeutix's Sales Annually?
OCUL Revenues are $58.4M -
How Much Profit Does Ocular Therapeutix's Make A Year?
OCUL net income is -$80.7M
Is Ocular Therapeutix Growing As A Company?
-
What Is Ocular Therapeutix's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.02% -
What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ocular Therapeutix Stock Price Performance
-
Did Ocular Therapeutix Stock Go Up Last Month?
Ocular Therapeutix share price went down by -14.96% last month -
Did OCUL's Share Price Rise Over The Last Year?
OCUL share price rose by 160.77% over the past 1 year
What Is Ocular Therapeutix 52-Week High & Low?
-
What Is Ocular Therapeutix’s 52-Week High Share Price?
Ocular Therapeutix has traded as high as $11.78 over the past 52 weeks -
What Is Ocular Therapeutix’s 52-Week Low Share Price?
Ocular Therapeutix has traded as low as $3.25 over the past 52 weeks
Ocular Therapeutix Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ocular Therapeutix?
-
How Much Debt Does Ocular Therapeutix Have?
Total long term debt quarterly is $67.8M -
How Much Cash Does Ocular Therapeutix Have?
Cash and short term investments quarterly total is $427.2M -
What Is Ocular Therapeutix’s Book Value Per Share?
Book value per share is 2.25
Is Ocular Therapeutix Cash Flow Positive?
-
What Is OCUL Cash Flow From Operations?
Cash flow from operations (TTM) is -$117.7M -
What Is Ocular Therapeutix’s Cash Flow From Financing?
Cash flow from financing (TTM) is $435.8M -
What Is Ocular Therapeutix’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.5M
Ocular Therapeutix Return On Invested Capital
-
Is Management Doing A Good Job?
OCUL return on invested capital is -54.93% -
What Is Ocular Therapeutix Return On Assets?
ROA measures how assets are converting to revenues and is -44.46% -
What Is OCUL Return On Equity?
ROE is a measure of profitability and is -70.49%
Ocular Therapeutix Earnings Date & Stock Price
-
What Is Ocular Therapeutix's Stock Price Today?
A single share of OCUL can be purchased today for 9.44 -
What Is Ocular Therapeutix’s Stock Symbol?
Ocular Therapeutix trades on the nasdaq under the ticker symbol: OCUL -
When Is Ocular Therapeutix’s Next Earnings Date?
The next quarterly earnings date for Ocular Therapeutix is scheduled on March 11, 2025 -
When Is OCUL's next ex-dividend date?
Ocular Therapeutix's next ex-dividend date is December 12, 2024 -
How To Buy Ocular Therapeutix Stock?
You can buy Ocular Therapeutix shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ocular Therapeutix Competitors
-
Who Are Ocular Therapeutix's Competitors?
Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
Ocular Therapeutix Dividend Yield
-
What Is OCUL Dividend Yield?
Ocular Therapeutix’s dividend yield currently is 0% -
What Is Ocular Therapeutix’s Payout Ratio?
Ocular Therapeutix’s payout ratio is 0% -
When Did Ocular Therapeutix Last Pay A Dividend?
The latest dividend pay date is December 12, 2024 -
What Is Ocular Therapeutix’s Dividend Per Share?
Ocular Therapeutix pays a dividend of $0.00 per share
Ocular Therapeutix Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -6.45% |
| Revenue: | 2.28% | -10.01% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 18.22 |
| Upside from Last Price: | 93.03% |